Status:
COMPLETED
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
6-60 years
Phase:
PHASE4
Brief Summary
A study of the effect of the early treatment with Pulmicort of newly diagnosed asthma. Patients will receive either Pulmicort or a non-active treatment for three years. Neither patients or investigato...
Eligibility Criteria
Inclusion
- Male or female patients aged between 6 and 60 years
- diagnosed with asthma within 2 years of starting the study
- Ability to use a Turbuhaler
Exclusion
- Symptoms indicating asthma (e.g. wheezing) for more than two years prior to starting the study
- A history of the use of treatments like Pulmicort for more than 30 days per year in the two years before starting the study
- Regular daily treatment for asthma for more than two years before starting the study
Key Trial Info
Start Date :
October 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2003
Estimated Enrollment :
6800 Patients enrolled
Trial Details
Trial ID
NCT00641914
Start Date
October 1 1996
End Date
February 1 2003
Last Update
March 25 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.